Novachor
Payments companies reported to CMS as associated with Novachor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Novachor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Novachor
These are the largest totals companies reported as associated with Novachor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Scott James | Plymouth, MA | Vascular Surgery | $193,200.00 |
| Robert Clemency III | Schererville, IN | Foot & Ankle Surgery | $83,747.85 |
| Daniel Kapp | West Palm Beach, FL | Plastic Surgery | $67,352.65 |
| Thomas Zwick | Miami, FL | Foot & Ankle Surgery | $56,473.70 |
| Michael Bain | Newport Beach, CA | Plastic Surgery | $52,143.70 |
| Amy Tucker | Stow, OH | Orthopaedic Surgery | $50,767.63 |
| Jeffrey Lehrman | Fort Collins, CO | Foot & Ankle Surgery | $49,929.56 |
| George Koullias | East Patchogue, NY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $47,986.95 |
| Eric Harmelin | Annapolis, MD | Foot & Ankle Surgery | $46,724.94 |
| Robert Davis | Bridgeport, CT | Podiatrist | $40,309.92 |
Prescribed Novachor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.